Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Active Ingredient Semaglutide (GLP-1 Receptor Agonist) Pen Strength 0.25 mg Semaglutide per delivery volume Delivery Tool 1 Multi-dose Disposable Pen + 4 Needles + 4 Swabs Primary Manufacturer Alkem Laboratories Ltd Administration Route Subcutaneous Injection (Weekly) Primary Indication Initiation / Starter Phase for Chronic Weight Loss & Diabetes Care
Not intended for human consumption, medical treatment, or veterinary application.
T-T (tesamorelin to tesamorelin) refers to the group of patients who received tesamorelin for Weeks 0-26 and were re-randomized to tesamorelin for Weeks 26-52
Cultivate Transparency Open communication with your healthcare provider is paramount
It is FDA-approved for weight loss and long-term weight management in adults and adolescents 12 years and older with obesity, as well as adults with overweight who have at least one weight-related health condition
A.WaterhamH
US$ 21.68
US$ 25.47
US$ 25.74
